TARDIVE DYSKINESIA AWARE. WEEK

Illinois General Assembly - Full Text of HR0723

Select Language

×

The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.

Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.

The English language version is always the official and authoritative version of this website.

NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.

Choose Language

English

Afrikaans

Albanian

Arabic

Armenian

Azerbaijani

Basque

Bengali

Bosnian

Catalan

Croatian

Czech

Danish

Dutch

Esperanto

Estonian

Filipino

Finnish

French

Galician

Georgian

German

Greek

Gujarati

Haitian Creole

Hausa

Hawaiian

Hebrew

Hindi

Hungarian

Icelandic

Indonesian

Interlingua

Interlingue

Inuktitut

Irish

Italian

Japanese

Javanese

Kannada

Khmer

Korean

Latin

Latvian

Lithuanian

Luxembourgish

Macedonian

Malagasy

Malayalam

Maltese

Maori

Marathi

Myanmar

Nepali

Norwegian

Odia

Pashto

Punjabi

Romanian

Russian

Samoan

Sango

Sanskrit

Sardinian

Sindhi

Sinhala

Slovak

Slovenian

Somali

Southern Sotho

Spanish

Sundanese

Swahili

Swedish

Tamil

Telugu

Thai

Tigrinya

Tonga

Turkish

Ukrainian

Urdu

Vietnamese

Welsh

Xhosa

Yiddish

Yoruba

Zulu

Powered by
Translate

Close

Illinois General Assembly

Top Navigation Bar

Translate

Learn

Select General Assembly

Search the 104th General Assembly

Enter search terms for legislation, members, committees, or schedules.

ILGA.GOV

LEGISLATION & LAWS

Bills & Resolutions

Public Acts

Illinois Compiled Statutes

Illinois Constitution

Search Legislation

Glossary

Guide

Reports & Inquiry

Legislative Reports

Special Reports

FTP Site

Legislator Lookup

Capitol Complex Phone Numbers

Rules & Regulations

Illinois Register

Administrative Rules

Senate

Members

Schedules

Committees

Request for Remote Testimony

Journals

Transcripts

Rules

Audio/Video

FOIA Information

Senate Employment Opportunities

Media Guidelines

House

Members

Schedules

Committees

Submit testimony for House Committees

Journals

Transcripts

Rules

Audio/Video

FOIA Information

House Employment Opportunities

Log In

Mobile Top Bar

Search the 104th General Assembly

Enter keywords to search the Illinois General Assembly website.

Full Text of HR0723

Home

Legislation

Full Text

HR0723 - 104th General Assembly

Bill Status

Full Text

Votes

Witness Slips

Select Menu

Bill Status

Full Text

Votes

Witness Slips

Printer Friendly Version

Introduced

Printer Friendly Version

Introduced

Open PDF

HR0723
LRB104 21017 LAW 34920 r
1
HOUSE RESOLUTION

2

WHEREAS, Serious mental illnesses like bipolar disorder,
3
major depressive disorder, and schizophrenia often require
4
treatment with antipsychotic medications for effective
5
management, and antipsychotic prescribing rates continue to
6
rise; and

7

WHEREAS, While prolonged antipsychotic use may be
8
essential for the treatment of certain conditions, it is
9
associated with tardive dyskinesia (TD), a condition marked by
10
uncontrollable, abnormal, and repetitive movements of the
11
face, torso, limbs, or extremities; and

12

WHEREAS, People at higher risk of TD include those older
13
than 55 years, people who are Black, women, individuals with
14
mood or substance use disorders, intellectual disabilities, or
15
central nervous system injuries, and those with high
16
cumulative antipsychotic exposure; and

17

WHEREAS, Approximately 60% of the estimated 800,000 U.S.
18
adults living with TD remain undiagnosed, and even mild TD
19
symptoms can be stigmatizing and impair physical, social, and
20
emotional well-being, underscoring the urgency of early
21
screening, detection, and intervention; and

HR0723
- 2 -
LRB104 21017 LAW 34920 r
1

WHEREAS, The American Psychiatric Association recommends
2
routine TD screening in their clinical guidelines for
3
antipsychotic treatment, and individuals treated with
4
antipsychotics or experiencing abnormal movements should
5
consult their health care providers to assess TD risk, receive
6
TD screenings, and determine appropriate treatment together;
7
and

8

WHEREAS, FDA-approved treatments for TD can provide
9
options for symptom management and improved quality of life
10
for many individuals living with TD; and

11

WHEREAS, The General Assembly can encourage TD screening
12
education and awareness for health care providers, patients,
13
and care partners to help ensure patients prescribed
14
antipsychotics receive care and support that aligns with
15
clinical best practices, including regular TD screenings;
16
therefore, be it

17

RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE
18
HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
19
we declare May 3 through May 9, 2026 as Tardive Dyskinesia
20
Awareness Week (TDAW) in the State of Illinois; and be it
21
further

22

RESOLVED, That we support TDAW in recognition of the

HR0723
- 3 -
LRB104 21017 LAW 34920 r
1
importance of early detection and intervention to improve
2
outcomes for people living with mental health conditions and
3
prescribed antipsychotics, and we support efforts to raise
4
awareness about the causes and symptoms of tardive dyskinesia
5
(TD) and the importance of routine TD screening.

Footer

Disclaimer

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.

Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn